Muscadine Plus (MPX) In Men With Prostate Cancer
Clinical trial NCT03535675 · TERMINATED
Trial details
- NCT number
- NCT03535675
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2018-10-30
- Primary completion
- 2022-07-06
- Enrollment
- 59
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.